Lipidor
0.244
SEK
-5.79 %
Less than 1K followers
LIPI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-5.79%
-18.12%
+14.55%
+44.38%
+92.89%
+130.79%
-86.32%
-92.49%
-86.2%
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Read moreMarket cap
198.47M SEK
Turnover
627.15K SEK
Revenue
14K
EBIT %
-101,500 %
P/E
-
Dividend yield-%
-
Financial calendar
3.6
2025
General meeting '25
28.8
2025
Interim report Q2'25
ShowingAll content types
Lipidor announces half of patients enrolled in ongoing Phase III study
Lipidor presents Nomination Committee
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools